Etirinotecan pegol: an option for late-stage breast cancer?

3 Citationer (Scopus)

Adgang til dokumentet

@article{f5332ca205f94625ac10304376894f77,

title = "Etirinotecan pegol: an option for late-stage breast cancer?",

author = "Nielsen, {Dorte L} and Br{\"u}nner, {Nils Aage}",

year = "2013",

month = nov,

doi = "10.1016/S1470-2045(13)70441-8",

language = "English",

volume = "14",

pages = "1149--51",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "The/Lancet Publishing Group",

number = "12",

}